不断发展的心脏肿瘤学领域

Cancer pathogenesis and therapy Pub Date : 2023-04-01 DOI:10.1016/j.cpt.2023.02.002

Guo Li, Lijun Zhang, Meiyan Liu

{"title":"不断发展的心脏肿瘤学领域","authors":"Guo Li, Lijun Zhang, Meiyan Liu","doi":"10.1016/j.cpt.2023.02.002","DOIUrl":null,"url":null,"abstract":"<div><p>Therapy development for cancer and cardiovascular disease (CVD) to prolong lifespan makes the relationship between these two conditions more complex. Drug interactions in cardiology and oncology are associated with metabolism and drug transportation. Advances in biomarkers and imaging provide novel methods for detecting cardiotoxicity, including cardiac injury and inflammation. The new concept of CVD-related cancer risk is leading to a new direction of progression termed “reverse cardio-oncology.”</p></div>","PeriodicalId":93920,"journal":{"name":"Cancer pathogenesis and therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Evolving field of cardio-oncology\",\"authors\":\"Guo Li, Lijun Zhang, Meiyan Liu\",\"doi\":\"10.1016/j.cpt.2023.02.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Therapy development for cancer and cardiovascular disease (CVD) to prolong lifespan makes the relationship between these two conditions more complex. Drug interactions in cardiology and oncology are associated with metabolism and drug transportation. Advances in biomarkers and imaging provide novel methods for detecting cardiotoxicity, including cardiac injury and inflammation. The new concept of CVD-related cancer risk is leading to a new direction of progression termed “reverse cardio-oncology.”</p></div>\",\"PeriodicalId\":93920,\"journal\":{\"name\":\"Cancer pathogenesis and therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer pathogenesis and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949713223000071\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer pathogenesis and therapy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949713223000071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

摘要

癌症和心血管疾病（CVD）延长寿命的治疗发展使这两种疾病之间的关系更加复杂。心脏病学和肿瘤学中的药物相互作用与代谢和药物运输有关。生物标志物和成像的进展为检测心脏毒性提供了新的方法，包括心脏损伤和炎症。与心血管病相关的癌症风险的新概念正在导致一种新的进展方向，称为“逆转心脏病学”

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Evolving field of cardio-oncology

Therapy development for cancer and cardiovascular disease (CVD) to prolong lifespan makes the relationship between these two conditions more complex. Drug interactions in cardiology and oncology are associated with metabolism and drug transportation. Advances in biomarkers and imaging provide novel methods for detecting cardiotoxicity, including cardiac injury and inflammation. The new concept of CVD-related cancer risk is leading to a new direction of progression termed “reverse cardio-oncology.”

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer pathogenesis and therapy Surgery, Radiology and Imaging, Cancer Research, Oncology

CiteScore

0.80

自引率

0.00%

发文量

审稿时长

54 days